arrow_back Civic Audit
Share share

No Tax Breaks for Prescription Drug Ads

This bill aims to prevent pharmaceutical companies from deducting the cost of prescription drug advertisements from their taxes. This means that drug ads seen on TV, online, or in newspapers will no longer reduce their tax obligations. This could impact the volume and type of drug advertisements citizens encounter.
Key points
Pharmaceutical companies will no longer be able to deduct the cost of prescription drug advertising from their taxes.
This change applies to direct-to-consumer advertising, including TV, radio, internet, newspapers, and billboards.
The goal is to potentially reduce the number of drug advertisements, which may affect consumer awareness of available medications.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_6392
Sponsor: Rep. Slotkin, Elissa [D-MI-8]
Process start date: 2022-01-13
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

No Tax Breaks for Drug Ads Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6392.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-01-13.

What are the main provisions?

Key points include:

  • Pharmaceutical companies will no longer be able to deduct the cost of prescription drug advertising from their taxes.
  • This change applies to direct-to-consumer advertising, including TV, radio, internet, newspapers, and billboards.
  • The goal is to potentially reduce the number of drug advertisements, which may affect consumer awareness of available medications.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Slotkin, Elissa [D-MI-8].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Taxes Health